⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of 1Elevan Biopharmaceuticals, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
1Elevan Biopharmaceuticals, Inc.
↗Fishers, Indiana, USA
1Elevan Biopharmaceuticals is a peptide therapeutics company that integrates specialized pharmacy operations with future cGMP manufacturing capabilities. The company focuses on providing FDA-compliant peptides, hormone replacement therapy (HRT/TRT), and IVIG therapeutics for complex patient needs, including solid organ transplant recipients.
Headquartered in Fishers, Indiana, the company aims to bridge the gap between early-stage research and patient access through a continuum of services, including 503A/503B compounding, telemedicine, and contract development and manufacturing (CDMO) services. Their model emphasizes precision medicine and provider-directed care.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Peptide Therapeutics / Specialty Pharmacy
SIZE & FINANCIALS
Employees:51-200
Founded:2022
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Early research and compounding
Modalities:Peptides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Potential future collaborations with Purdue University noted in expansion plans
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Darrin Carrico - President and CEO
LINKS
Website:1elevan.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with 1Elevan Biopharmaceuticals, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.